Menopause Coding Guidelines

Definition and Diagnosis

The National Comprehensive Cancer Network defines menopause clinically as the permanent cessation of menses with a profound decrease in ovarian estrogen synthesis, with specific criteria for determining menopausal status, including prior bilateral oophorectomy, age ≥60 years, or age <60 years with amenorrhea for 12+ months without chemotherapy, tamoxifen, or ovarian suppression, with FSH and estradiol in postmenopausal range 1, 2
The National Comprehensive Cancer Network recommends that if a woman is on tamoxifen/toremifene and age <60 years, FSH and estradiol levels must be in postmenopausal ranges to confirm menopausal status 1

Menopausal symptoms can significantly impact quality of life and include vasomotor symptoms (hot flashes/night sweats), vaginal dryness and urogenital complaints, sleep disturbances including insomnia, mood disturbances and depression, cognitive dysfunction, gastrointestinal symptoms including dyspepsia, arthralgias/myalgias, and sexual dysfunction 3, 4
The National Comprehensive Cancer Network guidelines suggest that symptoms such as fatigue, arthralgias, and myalgias should be coded separately when they are clinically significant and related to menopause 4, 6

The National Comprehensive Cancer Network recommends coding N959 (Unspecified menopausal and perimenopausal disorder) as the primary diagnosis, and adding specific symptom codes when symptoms are clinically significant and documented, directly related to menopause, and impacting quality of life or requiring treatment 2, 4
The Annals of Oncology suggests that symptom codes such as G4700 (Insomnia, unspecified), K30 (Dyspepsia), R53.83 (Fatigue), and M25.5 (Pain in joint) should be included when these symptoms are present and meet the above criteria 3, 4, 5, 6

The Annals of Oncology recommends documenting the frequency and severity of symptoms, assessing impact on daily activities and quality of life, using standardized assessment tools when available, and distinguishing between symptoms directly related to menopause versus those from other causes 3, 5
The National Comprehensive Cancer Network guidelines suggest avoiding under-coding, over-coding, and coding symptoms with other clear etiologies, and remembering that FSH is not a reliable marker of menopausal status in women on certain therapies or with prior chemotherapy 4, 5, 6